MaxCyte to Report First Quarter 2023 Financial Results on Ma

ROCKVILLE, Md., April 12, 2023 -- MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization... | April 12, 2023

Related Keywords

United Kingdom , Rupert Dearden , Emma Earl Freddy Crossley , David Deuchler , Panmure Gordon , Maxcyte Inc , Nasdaq , Twitter , Linkedin , Gilmartin Group , Flow Electroporation , Cyte Contacts , Joint Corporate , Maxcyte , Nc Stock Exchange , News , Information , Press Release , Pril , 023 , Ocused , Company , Roviding , Nabling , Platform , Technologies , O , Advance , The , Development , Nd Mxct Us57777k1060 ,